Labcorp Q2 revenue +5.8% to $3.73B, net income +25.6% to $298.7M; buybacks surge

Filed August 5, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 1, 2025 · ~1 min read

Key Changes

• high

  Revenue rose 5.8% to $3.73B, with organic growth of 4.2%, acquisitions adding 1.2%, and currency 0.4%.

  MD&A: Revenue verify on EDGAR →
• high

  Net income jumped 25.6% to $298.7M, and diluted EPS rose 28.2% to $3.64, driven by operating income growth and lower corporate expenses.

  MD&A: Operating income verify on EDGAR →
• high

  Share repurchases totaled $451.8M in H1 2026, more than double the prior year's $200.0M; board added $1.0B authorization on July 8, 2026.

  Notes: Share repurchases verify on EDGAR →